期刊文献+

胃癌患者外周血CD71/44、CD133/3的表达

Expression of CD71/44 and CD133/3 in peripheral blood of patients with gastric cancer
原文传递
导出
摘要 目的:研究胃癌患者外周血中CD71/44、CD133/3调节性T细胞(Tregulatory cells,Treg)的表达情况及与胃癌临床病理的关系。方法:胃癌患者外周血及正常对照组中Treg的表达情况以流式细胞仪进行检测,结合胃癌患者临床病理情况分析。结果:正常对照组外周血Treg表达率为CD71+/CD44+(11.62±3.26)%、CD133-/CD3+(24.53±9.86)%,胃癌患者外周血Treg表达率为CD71+/CD44+(15.6±7.56)%、CD133-/CD3+(28.64±10.98)%。患者均较正常对照组显著增高(P<0.05)。胃癌患者外周血Treg的表达与胃癌转移率和TNM分期呈负相关,胃癌转移阳性和TNM分期越晚,Treg表达率越高。结论:胃癌患者外周血调节性T细胞(Treg)的表达较正常对照组显著变化,并与临床病理存在一定相关性,有待进一步研究。 Objective : To evaluate the expressions of CD71/CD44 and CD133/3 T cells in peripheral blood from patients with gastric cancer, and study the correlation with clinical pathology of gastric cancer. Methods: The Treg cell expression level was detected in peripheral blood of gastric cancer patients and normal controls by flowcytometry. Results:The Treg expression levels were analyzed with clinical pathological information. The expression levels of Treg cells in control group were CD71 +/CD44 + ( 11.62 ± 3.26) % , CD133 -/CD3 + (24.53 ± 9.86) %, much lower than those in gastric cancer patients, CD71 +/CD44 + ( 15.6 ± 7.56) % , CD133 -/CD3 + (28.64 ± 10. 98 ) %. The expression level of Treg ceils in peripheral blood of gastric cancer patients was correlated negatively with lymph node metastasis and TNM classification. Conclusion:Treg ceils expression levels rose significantly in gastric cancer tissues and correlated with clinical information, indicating the immune state of gastric cancer patients.
作者 李午
出处 《中国卫生检验杂志》 北大核心 2013年第6期1505-1506,1509,共3页 Chinese Journal of Health Laboratory Technology
关键词 胃癌患者 外周血T淋巴细胞 CD71 44 CD133 3 流式细胞术 Patients with gastric cancer Peripheral blood T lymphocyte CD71/44 CD133/3 Flow cytometry
  • 相关文献

参考文献6

  • 1Curotto de Lafaille M A, Juan J Lafaille. CD44 + regulatory T cells in autoimmunity and allergy [ J]. Curren Opinion in Immunology,2002, 14(10) :771 -778.
  • 2Kruger K, Buning C, Schriever F, et al. Activated Tlymphocytes bind in situ to stromal tissue of colon carcinoma but lack adhesion to tumor cells[J]. Eur J Immunol. 2001, 31(2) :138 - 145.
  • 3李晓,陈怀增,谢幸,叶大风,吕卫国,丁志明.卵巢癌患者CD4^+CD25^+调节性T细胞比例增高的可能机制[J].中华微生物学和免疫学杂志,2004,24(7):538-539. 被引量:10
  • 4Siegel JP, Purl R K. Interleukin - 2 toxicity [ J ] . J filin Oncol, 1991,9 (8) :694.
  • 5Shevach E M. CD71 /CD44 suppressor T cells:more questions than answers [ J ]. Nature Rev Immunol,2002,2 ( 6 ) :389 - 400.
  • 6Mahzuz K, Andrew R B, Kathryn J W, et al . Regulatory T cells in transplantation [ J ]. Curren Opinion in Immunology, 2002, 14 ( 7 ) : 584 - 591.

二级参考文献4

  • 1Thornton AM, Shevach EM. CD4 + CD25 + immunoregulatory T cells suppress polyclonal T cell activation in vitro by inhibiting interleukin 2 production. J Exp Med, 1998, 188(2): 287-296.
  • 2Piccirillo CA, Shevah EM. Control of CD8+ T cell activation by CD4+CD25+ immunoregulatory cells. J Immunol, 2001, 167(3): 1137-1140.
  • 3Seo N, Hayakawa S, Takigawa M, et al. Interleukin-10 expressed at early tumor sites induces subsequent generation of CD4+ T-regulatory cells and systemic collapse of antitumour immunity. Immunology, 2001, 103(4):449-457.
  • 4Steitz J, Bruck J, Lenz J, et al. Depletion of CD25 + CD4 + T cells and treatment with tyrosinase-related protein 2-transduced dendritic cells enhance the interferon α-induced, CD8 + T cell dependent immune defense of B 16 melanoma. Cancer Res, 2001, 61(

共引文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部